Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd.
Hughes TP, Munhoz E, Aurelio Salvino M, Ong TC, Elhaddad A, Shortt J, Quach H, Pavlovsky C, Louw VJ, Shih LY, Turkina AG, Meillon L, Jin Y, Acharya S, Dalal D, Lipton JH. Hughes TP, et al. Among authors: quach h. Br J Haematol. 2017 Oct;179(2):219-228. doi: 10.1111/bjh.14829. Epub 2017 Jul 12. Br J Haematol. 2017. PMID: 28699641 Free PMC article. Clinical Trial.
Serum protein electrophoresis: a precautionary tale.
Grigoriadis G, Shortt J, Quach H, Opat S. Grigoriadis G, et al. Among authors: quach h. Pathology. 2012 Jun;44(4):371-373. doi: 10.1097/PAT.0b013e328353be32. Pathology. 2012. PMID: 28193342 No abstract available.
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
Quach H, Fernyhough L, Henderson R, Corbett G, Baker B, Browett P, Blacklock H, Forsyth C, Underhill C, Cannell P, Trotman J, Neylon A, Harrison S, Link E, Swern A, Cowan L, Dimopoulos MA, Miles Prince H. Quach H, et al. Br J Haematol. 2017 May;177(3):441-448. doi: 10.1111/bjh.14562. Epub 2017 Feb 15. Br J Haematol. 2017. PMID: 28197996 Free article. Clinical Trial.
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.
Tatarczuch M, Paul E, Gilberston M, Gregory GP, Tam C, Quach H, Bazargan A, Filshie R, Ku M, Tey A, Shortt J, Opat S. Tatarczuch M, et al. Among authors: quach h. Leuk Lymphoma. 2021 Jan;62(1):112-117. doi: 10.1080/10428194.2020.1821007. Epub 2020 Sep 27. Leuk Lymphoma. 2021. PMID: 32981406
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR).
McQuilten Z, Wellard C, Moore E, Augustson B, Bergin K, Blacklock H, Harrison S, Ho PJ, King T, Quach H, Mollee P, Rosengarten B, Walker P, Wood E, Spencer A; Australian and New Zealand Myeloma and Related Diseases Registry. McQuilten Z, et al. Among authors: quach h. Br J Haematol. 2022 Sep;198(5):830-837. doi: 10.1111/bjh.18324. Epub 2022 Jul 11. Br J Haematol. 2022. PMID: 35818641 Free PMC article.
A sequential cohort study evaluating single-agent KappaMab and KappaMab combined with lenalidomide and low-dose dexamethasone in relapsed and/or refractory kappa light chain-restricted multiple myeloma (AMaRC 01-16).
Spencer A, Kalff A, Shortt J, Quach H, Wallington-Gates C, Reynolds J, Walker P, Harrison SJ, Dunn R, Wellard C. Spencer A, et al. Among authors: quach h. Br J Haematol. 2023 Aug;202(4):801-811. doi: 10.1111/bjh.18955. Epub 2023 Jun 26. Br J Haematol. 2023. PMID: 37357593 Clinical Trial.
Failure of eculizumab to correct paroxysmal cold hemoglobinuria.
Gregory GP, Opat S, Quach H, Shortt J, Tran H. Gregory GP, et al. Among authors: quach h. Ann Hematol. 2011 Aug;90(8):989-90. doi: 10.1007/s00277-010-1123-x. Epub 2010 Nov 26. Ann Hematol. 2011. PMID: 21110191 No abstract available.
348 results